CytoDyn (CYDY) Proxy Filing summary

Executive summary

• The 2024 Annual Meeting will be held virtually on November 22, 2024, with voting eligibility for shareholders of record as of September 30, 2024.

• Key proposals include electing five directors, ratifying the appointment of Marcum LLP as auditor, and an advisory vote on executive compensation.

• The Board recommends voting in favor of all proposals and nominees.

Voting matters and shareholder proposals

• Shareholders will vote on electing five directors, ratifying Marcum LLP as auditor, and approving executive compensation on an advisory basis.

• The Board recommends voting “FOR” all nominees and proposals.

• Shareholders can vote online, by phone, or by mail, and may revoke proxies before the meeting.

• Proposals 1 and 3 are expected to be non-routine, requiring explicit voting instructions from brokers.

• Shareholder proposals for the 2025 meeting must be submitted between July 25 and August 25, 2025.

Board of directors and corporate governance

• The Board consists of five independent directors, all nominated for re-election.

• Board committees include Audit, Compensation, and Nominating and Corporate Governance, each with independent members.

• The Board is chaired by an independent director, with a policy of director attendance at annual meetings.

• The Nominating Committee considers diversity and ethical behavior in director selection.

• An anti-hedging policy prohibits directors and employees from engaging in certain stock transactions.